Client: The Royal Melbourne hospital
Context: SEISMIC is a single-arm clinical trial for patients with early-stage non-small-cell lung cancer (NSCLC).
This was the first multi-centre and international study – involving sites in Australia, the Netherlands, USA and Canada – to prospectively show the benefits of endoscopic staging in NSCLC patients with locally advanced cancers.
For more information, see:
- Lancet Respiratory Medicine article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00010-9/abstract
- https://www.sciencedirect.com/science/article/pii/S2213260024000109
- Peter McCallum news: https://www.petermac.org/about-us/news-and-events/news/details/new-approach-to-understanding-extent-of-lung-cancer-at-diagnosis
